142 related articles for article (PubMed ID: 2952649)
1. Specific residues within an amino-terminal domain of 35 residues of interferon alpha are responsible for recognition of the human interferon alpha cell receptor and for triggering biological effects.
Shafferman A; Velan B; Cohen S; Leitner M; Grosfeld H
J Biol Chem; 1987 May; 262(13):6227-37. PubMed ID: 2952649
[TBL] [Abstract][Full Text] [Related]
2. Biological activities and receptor binding of two human recombinant interferons and their hybrids.
Meister A; Uzé G; Mogensen KE; Gresser I; Tovey MG; Grütter M; Meyer F
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1633-43. PubMed ID: 3016158
[TBL] [Abstract][Full Text] [Related]
3. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
4. In vitro biological activities of Escherichia coli-derived bovine interferons-alpha, -beta, and -gamma.
Czarniecki CW; Hamilton EB; Fennie CW; Wolf RL
J Interferon Res; 1986 Feb; 6(1):29-37. PubMed ID: 2939154
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
[TBL] [Abstract][Full Text] [Related]
6. Receptors for human interferon alpha on bovine cells: specificity and tissue distribution.
Chambers PJ; Saltis J; Alin P; Wright A; Linnane AW; Cheetham BF
Immunopharmacol Immunotoxicol; 1990; 12(3):513-25. PubMed ID: 2148343
[TBL] [Abstract][Full Text] [Related]
7. Receptors for human alpha interferon: are gangliosides involved?
Gupta SL; Raziuddin A; Sarkar FH
J Interferon Res; 1984; 4(3):305-14. PubMed ID: 6238109
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of HuIFN-gamma on 2',5'-oligoadenylate synthetase induction by HuIFN-alpha.
Justesen J; Berg K
J Interferon Res; 1986 Aug; 6(4):445-54. PubMed ID: 3095443
[TBL] [Abstract][Full Text] [Related]
9. An interferon analogue, [Ala 30,32,33]HuIFN-alpha 2, acting as a HuIFN-alpha 2 antagonist on bovine cells.
Marcucci F; De Maeyer E
Biochem Biophys Res Commun; 1986 Feb; 134(3):1412-8. PubMed ID: 3004491
[TBL] [Abstract][Full Text] [Related]
10. Characterization and signaling pathway analysis of interferon-kappa in bovine.
Guo Y; An D; Liu Y; Bao J; Luo X; Cheng X; Wang Y; Gao M; Wang J
Dev Comp Immunol; 2017 Feb; 67():213-220. PubMed ID: 27693540
[TBL] [Abstract][Full Text] [Related]
11. Interferon-tau and interferon-alpha interact with the same receptors in bovine endometrium. Use of a readily iodinatable form of recombinant interferon-tau for binding studies.
Li J; Roberts RM
J Biol Chem; 1994 May; 269(18):13544-50. PubMed ID: 8175789
[TBL] [Abstract][Full Text] [Related]
12. The role of three domains in the biological activity of human interferon-alpha.
Fish EN; Banerjee K; Stebbing N
J Interferon Res; 1989 Feb; 9(1):97-114. PubMed ID: 2523943
[TBL] [Abstract][Full Text] [Related]
13. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of a bovine alpha interferon receptor.
Lim JK; Langer JA
Biochim Biophys Acta; 1993 Jun; 1173(3):314-9. PubMed ID: 8318540
[TBL] [Abstract][Full Text] [Related]
15. Somatic cell mapping of the bovine interferon-alpha receptor.
Langer JA; Puvanakrishnan R; Womack JE
Mamm Genome; 1992; 3(4):237-40. PubMed ID: 1535250
[TBL] [Abstract][Full Text] [Related]
16. VIP induces in HT-29 cells 2'5'oligoadenylate synthetase and antiviral state via interferon beta/alpha synthesis.
Chelbi-Alix MK; Boissard C; Sripati CE; Rosselin G; Thang MN
Peptides; 1991; 12(5):1085-93. PubMed ID: 1724797
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and biological activity of bovine interferon-omega3.
An D; Guo Y; Bao J; Luo X; Liu Y; Ma B; Gao M; Wang J
Res Vet Sci; 2017 Dec; 115():125-131. PubMed ID: 28254416
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome.
Lau AS; Read SE; Williams BR
J Clin Invest; 1988 Oct; 82(4):1415-21. PubMed ID: 2971677
[TBL] [Abstract][Full Text] [Related]
19. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
Cutrone EC; Langer JA
J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
[TBL] [Abstract][Full Text] [Related]
20. Structure/function studies on recombinant human gamma interferon.
Fish EN; Banerjee K; Arakawa T; Stebbing N
Drug Des Deliv; 1988 Feb; 2(3):191-206. PubMed ID: 2855574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
